Efficacy of Umbilical cord Mesenchymal stem cells transplantation in the treatment of brainstem disease patients

Efficacy ofUmbilical cord Mesenchymal stem cells transplantation in the treatment of brainstem disease patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNC-11001486

Enrollment

Unknown

Registered

2011-08-25

Start date

2011-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brainstem chronic diseases: including the brainstem hemorrhage, brainstem infarct and brain stem injury and other causes leading to the formation of malacia of the brainstem.

Interventions

Group A:Mesenchymal stem cells transplantation

Eligibility

Sex/Gender

All

Age

5 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Brainstem chronic diseases: including the brainstem hemorrhage, brainstem infarct and brain stem injury and other causes leading to the formation of malacia of the brainstem; 2. Clearly diagnosis on CT or MRI.

Exclusion criteria

Exclusion criteria: 1. Acute cerebral vascular disease; 2. Severe cardiovascular disease; 3. Imunocompromised or using immunosuppressive agents.

Design outcomes

Primary

Measure	Time frame
Electricity physical check;	—

Secondary

Measure	Time frame
FIM score;FIM score;	—

Countries

China

Contacts

Public ContactYihua An

riveran@163.com+86 10 57976848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026